UH researcher joins $3.2 million effort to develop promising new breast cancer treatment
Research targets deadly triple-negative breast cancer
Research targets deadly triple-negative breast cancer
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer’s biology.
“Our data demonstrates that SB-216 effectively inhibits PDAC cell growth through inhibiting oncogenic microtubules and mitochondrial function”
As the FDA moves to finalize a rule requiring front-of-package (FOP) nutrition labels on most packaged foods and beverages in the US, new research suggests that while the proposed “Nutrition Info Box,” showing levels of saturated fat, sodium, and added sugar, was found to work best for consumers who had higher nutrition literacy, it may… Read More
Cancer researchers at the University of Tennessee Health Science Center have published three groundbreaking studies demonstrating how advanced artificial intelligence and population health analytics can identify and address barriers to quality cancer care.
The findings strongly suggest that genetic testing should be done on all children with heart failure and myocarditis
A transparent chip no larger than a stick of gum is helping scientists at the University of Tennessee Health Science Center, an R1 research institution, transform the way researchers study the human brain and develop treatments for some of the world’s deadliest viruses.
Scientists at St. Jude Children’s Research Hospital have found a way to use a bacterium’s own drug resistance mechanisms against itself, presenting a potentially safer and more effective way to treat certain antibiotic-resistant infections.